Bridion 200 MG/2 ML vial 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9K11
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $117,277
Award facts
- Contract value 100% obligated
- $117,276.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $117,276.89 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 ml vials on November 28, 2025, with an ultimate completion date of December 1, 2025. This competitive, non-set-aside award operates under a firm fixed-price contract structure and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's SPE2DX contract functions as a comprehensive global pharmaceutical support vehicle enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers worldwide. This delivery order for Bridion, a neuromuscular blocking reversal agent used in anesthesia, represents one of numerous pharmaceutical product deliveries the company fulfills through its DLA contract portfolio, demonstrating its substantial role in sustaining federal medical supply chains.
Quick answers
Who was awarded contract SPE2DR26F9K11?
SPE2DR26F9K11 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26F9K11 worth?
The government has obligated $117,277 on SPE2DR26F9K11.
Is contract SPE2DR26F9K11 an order under another contract?
Yes. SPE2DR26F9K11 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9K11 competed?
The extent of competition for SPE2DR26F9K11 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award